What is the DAWN EFFECT? High Morning Blood Sugars (2026)

Why Your Fasting Blood Sugar Is Higher Than You Expected

You have been eating well. You took your GLP-1 medication on schedule. You fasted overnight for twelve hours. And then you check your blood sugar first thing in the morning and it is higher than it was before bed. What gives? Dr. Ken Berry, whose metabolic health content reaches millions, explains the dawn phenomenon in this video with 119K views, and the explanation has direct relevance for everyone monitoring their blood sugar on GLP-1 therapy.

The dawn phenomenon (sometimes called the dawn effect) is a natural physiological process where blood sugar rises in the early morning hours, typically between 3:00 AM and 8:00 AM, even though you have not eaten anything. It confuses patients, frustrates physicians, and generates countless anxious questions in online health communities. But it is not a sign that your medication is failing. It is a sign that your body is doing something it has evolved to do.

The Biology Behind Morning Blood Sugar Spikes

In the hours before you wake up, your body begins preparing for the day. This preparation involves releasing several hormones that raise blood sugar to ensure your brain and muscles have ready fuel for the activities of the morning. The primary players are cortisol (the stress and wakefulness hormone), growth hormone, glucagon, and catecholamines (adrenaline and noradrenaline).

Cortisol follows a circadian pattern, hitting its daily peak between 6:00 and 9:00 AM. This cortisol surge is what helps you wake up and feel alert. But cortisol also signals the liver to release stored glucose (glycogen) into the bloodstream through a process called gluconeogenesis. Growth hormone, which is released in pulses during deep sleep, also promotes hepatic glucose output. The combined effect is a measurable rise in blood sugar that occurs even during complete fasting.

In people with normal glucose regulation, the pancreas responds to this morning glucose rise by releasing insulin, which quickly clears the excess glucose into cells. The blood sugar spike is brief and mild, and most people never notice it. But in people with insulin resistance or type 2 diabetes, the insulin response is sluggish or insufficient. The glucose stays elevated longer, and the fasting blood sugar reading reflects this sustained elevation.

Why This Matters on GLP-1 Therapy

GLP-1 medications improve glucose control through multiple mechanisms: they stimulate insulin release in response to food, suppress glucagon secretion (which reduces hepatic glucose output), and slow gastric emptying (which reduces post-meal glucose spikes). However, the dawn phenomenon operates partly through pathways that GLP-1 medications do not fully suppress, particularly the cortisol-driven hepatic glucose release.

This is why some patients on GLP-1 therapy see excellent post-meal blood sugars (because the medication is working on those meal-related pathways) but still have frustratingly elevated fasting morning readings (because the dawn phenomenon is driven by hormones that are less responsive to GLP-1 intervention). It does not mean the medication is not working. It means the medication is working on the things it targets, but the dawn phenomenon has additional hormonal drivers.

Dr. Berry points out that fixating on fasting blood sugar as the sole metric of glucose control can be misleading. A patient whose fasting glucose is 120 mg/dL but whose post-meal glucose never exceeds 140 mg/dL and whose HbA1c is 5.8% is in dramatically better metabolic shape than their fasting number suggests. The fasting number captures the dawn phenomenon spike, but the rest of the day may reflect excellent glucose management.

Practical Strategies to Manage the Dawn Effect

Dr. Berry covers several evidence-backed approaches to reducing the dawn phenomenon. The first is evening or bedtime exercise. Physical activity depletes liver glycogen stores, which means there is less stored glucose available for the early-morning cortisol-driven release. A 15-20 minute walk after dinner, or a brief resistance training session in the evening, can measurably reduce the next morning's fasting glucose.

The second is adjusting the timing of your last meal or snack. Some patients find that a small, protein-and-fat-focused bedtime snack (a handful of nuts, a few ounces of cheese, a tablespoon of peanut butter) reduces the dawn effect. The mechanism may involve maintaining a low but steady insulin level through the night that partially counteracts the cortisol-driven glucose release. This does not work for everyone, and some patients find that any eating close to bedtime worsens their numbers. Individual experimentation is needed.

The third is medication timing. For patients on GLP-1 therapy plus other diabetes medications (metformin, for example), taking metformin at bedtime rather than in the morning can reduce overnight hepatic glucose production and lower the fasting reading. This is a conversation to have with your prescribing physician, not a change to make on your own.

The Somogyi Effect: A Different Morning Problem

Dr. Berry also distinguishes the dawn phenomenon from the Somogyi effect (rebound hyperglycemia), which looks similar but has a different cause and different implications. The Somogyi effect occurs when blood sugar drops too low during the night (often due to too much insulin or another glucose-lowering medication), triggering a counter-regulatory hormone response that overshoots, producing a high morning reading.

The way to distinguish between the two is to check blood sugar at 2:00-3:00 AM (or use a continuous glucose monitor that records overnight). If the 3 AM reading is normal or high, the morning spike is the dawn phenomenon. If the 3 AM reading is low (below 70 mg/dL), the morning spike is a Somogyi rebound, and the overnight medication dose may need to be reduced to prevent the nocturnal low.

This distinction matters because the treatments are opposite. The dawn phenomenon may benefit from more overnight glucose-lowering medication. The Somogyi effect requires less overnight medication. Getting it wrong can make things worse, which is why overnight glucose monitoring is valuable for patients with persistently elevated fasting readings.

Continuous Glucose Monitoring Changes the Picture

Dr. Berry discusses the value of continuous glucose monitors (CGMs) for understanding the dawn phenomenon and overall glucose patterns. A CGM provides a reading every 5-15 minutes, creating a continuous picture of glucose trends rather than isolated point-in-time snapshots. For patients trying to understand why their morning number is high, a CGM shows exactly when the rise begins, how steep it is, and how long it takes to come down.

Many GLP-1 patients who are not diabetic are now using CGMs to optimize their metabolic health and monitor their response to medication. For these users, the dawn phenomenon can be particularly confusing because their overall glucose control may be excellent but the morning spike creates anxiety about a single elevated number.

The CGM perspective is reassuring for most patients: the dawn spike is temporary, the glucose comes down after a few hours, and the overall glucose profile (measured by time in range and average glucose) is more important than any single reading. If your time in range (70-140 mg/dL) is 70% or higher and your average glucose corresponds to an HbA1c below 6.0%, you are doing well even if your fasting number is higher than you would like.

When to Be Concerned

While the dawn phenomenon is normal physiology, persistently high fasting glucose that does not respond to lifestyle modifications or medication adjustment can signal worsening insulin resistance or progressive beta cell dysfunction. If your fasting glucose is consistently above 130 mg/dL despite GLP-1 therapy and lifestyle optimization, or if your HbA1c is rising despite medication compliance, these are signs that your treatment plan may need intensification.

Dr. Berry recommends working with your physician to track trends over weeks and months rather than reacting to individual morning readings. Glucose control is a long game, and the dawn phenomenon is a normal wrinkle in that game, not a sign of failure. Understanding what it is, why it happens, and what you can realistically do about it gives you the context to interpret your numbers without unnecessary stress.

The Lifestyle Medicine Approach to Morning Glucose

Beyond targeted dawn phenomenon strategies, Dr. Berry discusses how broader lifestyle factors influence morning glucose over time. Chronic stress amplifies the dawn effect because elevated baseline cortisol means the morning cortisol surge starts higher and produces a more dramatic glucose response. Stress management practices like regular exercise, adequate sleep, mindfulness, and time outdoors can gradually reduce chronic cortisol elevation and moderate the dawn phenomenon.

Body composition changes also affect the dawn effect over time. As GLP-1 patients lose visceral fat, their liver becomes more insulin-sensitive and less responsive to cortisol-driven glucose release signals. Many patients find fasting glucose gradually improves over months of treatment, not because the dawn phenomenon disappears, but because the liver overreaction to morning cortisol diminishes as whole-body insulin sensitivity improves.

Alcohol consumption in the evening can affect morning blood sugar unpredictably. Alcohol initially lowers blood sugar by suppressing hepatic gluconeogenesis, but this drop can trigger counter-regulatory hormones that produce a rebound glucose rise in early morning hours. Patients who notice worse fasting glucose after evenings with alcohol may benefit from reducing evening consumption, a change GLP-1 medications often make easier due to reduced alcohol cravings.

The key message is that the dawn phenomenon signals your body functioning normally, even if insulin resistance exaggerates the magnitude. As metabolic health improves through medication, weight loss, exercise, and nutrition, the dawn effect typically moderates. It may never disappear entirely, but it should not remain a source of daily anxiety if your broader glucose control is trending in the right direction.